Improved renal allograft survival with vitamin D receptor polymorphism

Renal Failure

Volumn 29, Issue 7, 2007, Pages 785-789

  Lavin, P J ^a,c   Laing, M E ^a   O'Kelly, P ^a   Moloney, F J ^a   Gopinathan, D ^a   Aradi, A Al ^a   Shields, D C ^b   Murphy, G M ^a   Conlon, P J ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Immune modulation; Renal transplant; VDR agonists; VDR polymorphism

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; ALLELE; ARTICLE; DATA ANALYSIS; DISEASE COURSE; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GRAFT SURVIVAL; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

ADULT; AGED; FEMALE; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; TRANSPLANTATION, HOMOLOGOUS;

EID: 36248930530     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220701540417     Document Type: Article

References (21)

1. Wolfe R, Ashby V, Milford E, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725-1730.
2. Overbeck I, Bartels M, Decker O, Harms J, Hauss J, Fangmann J. Changes in quality of life after renal transplantation. Transplant Proc. 2005;37:1618-1621.
3. Griffin M, Xing N, Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr. 2003;23:117-145.
4. Norman A, Mizwicki M, Okamura W. Ligand structure-function relationships in the vitamin D endocrine system from the perspective of drug development (including cancer treatment). Recent Results Cancer Res. 2003;164:55-82.
5. Liu Z, Calderon J, Zhang Z, Sturgis E, Spitz M, Wei Q. Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer. Pharmacogenet Genomics. 2005;15:159-165.
6. Norman A, Ishizuka S, Okamura W. Ligands for the vitamin D endocrine system: Different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein. J Steroid Biochem Mol Biol. 2001;76:49-59.
7. Gross C, Eccleshall T, Malloy P, Villa M, Marcus R, Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res. 1996;11:1850-1855.
8. Jurutka P, Remus L, Whitfield G, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol. 2000;14:401-420.
9. Maalej A, Petit-Teixeira E, Michou L, Rebai A, Cornelis F, Ayadi H. Association study of VDR gene with rheumatoid arthritis in the French population. Genes Immun. 2005;6:707-711.
10. Simmons J, Mullighan C, Welsh K, Jewell D. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut. 2000;47:211-214.
11. Uitterlinden A, Fang Y, Van Meurs J, Pols H, Van Leeuwen J. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338:143-156.
12. Wilcken B, Bamforth F, Li Z, et al. Geographical and ethnic variation of the 677C>T allele of 5, 10 methylenetetrahydrofolate reductase (MTHFR): Findings from over 7000 newborns from 16 areas world wide. J Med Genet. 2003;40:619-625.
13. Adorini L. Intervention in autoimmunity: The potential of vitamin D receptor agonists. Cellular Immunology. 2005;233:115-124.
14. Bhalla A, Amento E, Serog B, Glimcher L. 1,25- Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol. 1984;133:1748-1754.
15. Alroy I, Towers T, Freedman L. Transcriptional repression of the interleukin-2 gene by vitamin D3: Direct inhibition NFATp/ AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol. 1995;15:5789-5799.
16. Cippitelli M, Santoni A. Vitamin D3: A transcriptional modulator of the interferon-gamma gene. Eur J Immunol. 1998;28:3017-3030.
17. Mattner F, Smiroldo S, Galbiati F, et al. Inhibition of Th1 development and treatment of chronic relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D3. Eur J Immunol. 2000;30:498-508.
18. Kallio E, Hayry P, Pakkala S. MC1288, a vitamin D analogue, reduces short- and long-term renal allograft rejection in the rat. Transplant Proc. 1996;28:3113.
19. Amuchastegui S, Daniel K, Adorini L. Inhibition of acute and chronic allograft rejection in mouse models by BXL-628, a nonhypercalcemic vitamin D receptor agonist. Transplantation. 2005;80:81-87.
20. Redaelli C, Wagner M, Gunter-Duwe D, et al. 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants. Kidney Int. 2002;61:288-296.
21. O'Herrin J, Hullett D, Heisey D, Sollinger H, Becker B. A retrospective evaluation of 1, 25-dihydroxyvitamin D (3) and its potential effects on renal allograft function. Am J Nephrol. 2002;22:515-520.